Mersana Therapeutics, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
MRSN on Nasdaq
Industry
Pharmaceutical Preparations
Location
840 Memorial Drive, Cambridge, Massachusetts

Insiders trading volume in the past year

Mersana Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
EcoR1 Capital, LLC 10%+ Owner $52.5 M Jul 27, 2023
David M. Mott Director $1.62 M Jun 11, 2024
Timothy B. Lowinger SVP, Chief Sci.&Tech. Officer $676 K -$28.2 K -4.01% Jan 13, 2024
Anna Protopapas Director $535 K -$79.7 K -13% Jun 11, 2024
Brian DeSchuytner Svp, Coo & Cfo $306 K -$25.3 K -7.63% Jan 13, 2024
Alejandra Carvajal SVP, Chief Legal Officer $210 K -$11.9 K -5.36% Jan 13, 2024
Mohan Bala SVP, Chief Development Officer $196 K -$11.5 K -5.52% Jan 13, 2024
Tushar Misra SVP, Chief Manuf. Officer $162 K -$11.3 K -6.56% Jan 13, 2024
Arvin Yang SVP, Chief Medical Officer $141 K Jan 13, 2023
Martin H. Huber Jr. President, CEO, Director $120 K Jan 15, 2024
Ashish Mandelia VP, Chief Accounting Officer $108 K -$13.6 K -11.2% Jan 13, 2024
Willard H. Dere Director $106 K Jun 11, 2024
Michael J. Kaufman Chief Manufacturing Officer $88.4 K Jul 15, 2021
Lawrence M. Alleva Director Jul 1, 2024
Kristen Hege Director Jun 11, 2024
Allene M. Diaz Director Jun 11, 2024
Andrew Hack Director Jun 11, 2024

Recent Insider Transactions by Companies or Individuals for Mersana Therapeutics, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership